Power Law company profile

AIM Vaccine

Biotech & Life Sciences · Daxing District, China · Founded 2011 · IPO 2022 Thoroughbred

A large-scale private vaccine group in China with the entire industry chain

Valuation

$544M

Market cap · May/2026

Revenue

$160M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Global footprint

Where AIM Vaccine has talent and traffic

Workforce by country

🇨🇳 China · Daxing District HQ

Book a demo for the full country breakdown

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States11.3%

🇨🇦 Canada4.8%

🇮🇳 India3%

Top 3 markets shown

Market sentiment

What the market is saying about AIM Vaccine

An AI-synthesized read of the highest-engagement posts about AIM Vaccine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AIM Vaccine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles